The global body contouring devices market size is calculated at USD 1.75 billion in 2024, grew to USD 2.00 billion in 2025 and is projected to reach around USD 6.67 billion by 2034. The market is expanding at a CAGR of 14.32% between 2024 and 2034. The North America body contouring devices market size is evaluated at USD 620 million in 2024 and is expected to grow at a CAGR of 14.34% during the forecast year.
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Body Contouring Devices Industry Impact
5.2. COVID-19 Impact Assessment for the Industry
5.3. COVID-19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Body Contouring Devices Market Revenue and Volume, by Type, 2024-2034
8.1.1. Non-Invasive And Minimally Invasive Devices
8.1.1.1. Market Revenue and Volume Forecast (2021-2034)
8.1.2. Invasive Devices
8.1.2.1. Market Revenue and Volume Forecast (2021-2034)
9.1. North America
9.1.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.1.2. U.S.
9.1.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.1.3. Rest of North America
9.1.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.2. Europe
9.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.2.2. UK
9.2.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.2.3. Germany
9.2.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.2.4. France
9.2.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.2.5. Rest of Europe
9.2.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.3. APAC
9.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.3.2. India
9.3.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.3.3. China
9.3.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.3.4. Japan
9.3.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.3.5. Rest of APAC
9.3.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.4. MEA
9.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.4.2. GCC
9.4.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.4.3. North Africa
9.4.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.4.4. South Africa
9.4.4.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.4.5. Rest of MEA
9.4.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.5. Latin America
9.5.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.5.2. Brazil
9.5.2.1. Market Revenue and Volume Forecast, by Type (2021-2034)
9.5.3. Rest of LATAM
9.5.3.1. Market Revenue and Volume Forecast, by Type (2021-2034)
10.1. Allergan
10.1.1. Company Overview
10.1.2. Product Offerings
10.1.3. Financial Performance
10.1.4. Recent Initiatives
10.2. Alma Lasers
10.2.1. Company Overview
10.2.2. Product Offerings
10.2.3. Financial Performance
10.2.4. Recent Initiatives
10.3. Candela Corporation
10.3.1. Company Overview
10.3.2. Product Offerings
10.3.3. Financial Performance
10.3.4. Recent Initiatives
10.4. Cynosure
10.4.1. Company Overview
10.4.2. Product Offerings
10.4.3. Financial Performance
10.4.4. Recent Initiatives
10.5. Fotona
10.5.1. Company Overview
10.5.2. Product Offerings
10.5.3. Financial Performance
10.5.4. Recent Initiatives
10.6. Inmode Ltd
10.6.1. Company Overview
10.6.2. Product Offerings
10.6.3. Financial Performance
10.6.4. Recent Initiatives
10.7. Lumenis
10.7.1. Company Overview
10.7.2. Product Offerings
10.7.3. Financial Performance
10.7.4. Recent Initiatives
10.8. Lutronic Corporation
10.8.1. Company Overview
10.8.2. Product Offerings
10.8.3. Financial Performance
10.8.4. Recent Initiatives
10.9. Merz Pharma Gmbh
10.9.1. Company Overview
10.9.2. Product Offerings
10.9.3. Financial Performance
10.9.4. Recent Initiatives
10.10. Sciton Inc.
10.10.1. Company Overview
10.10.2. Product Offerings
10.10.3. Financial Performance
10.10.4. Recent Initiatives
11.1. Primary Research
11.2. Secondary Research
11.3. Assumptions
12.1. About Us
12.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample